Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Phase III clinical trials
.
Show all posts
Showing posts with label
Phase III clinical trials
.
Show all posts
Thursday, August 8, 2013
Phase III trial shows afatinib offers clinical benefit to patients with EGFR mutation positive NSCLC
›
We know that, Afatinib ( INN ; trade name Gilotrif , previously Tomtovok and Tovok ) is an approved drug against non-small ...
›
Home
View web version
